The GO analysis results showed that the potential targets of melittin for RA treatment are closely related to various pathways and components, such as the response to LPS, bacteria, TNF, and ROS, as well as the processes of cytokine–receptor binding, substrate dephosphorylation, and protein kinase activation. This evidence concerns the gene TNF and rheumatoid arthritis.